Efficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women

Article information

Obstet Gynecol Sci. 2024;67(4):430-430

Publication date (electronic) : 2024 May 28

doi : https://doi.org/10.5468/ogs.2017.60.2.213.e1

Bo Ra Park , Hye Na Park , Ji Back Jung , Eun Sil Lee , Jeong Sig Kim , Gyu Yeon Choi , Jeong Jae Lee , Im Soon Lee

Department of Obstetrics and Gynecology, Soonchunhyang University College of Medicine, Asan, Korea

In the published article, “Bo Ra Park, et al. Efficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women. Obstet Gynecol Sci 2017;60(2):213-217. https://doi.org/10.5468/ogs.2017.60.2.213,” one of the authors’ names was published incorrectly.

Before correction

Bo Ra Park, Hye Na Park, Ji Back Jung, Eun Sil Lee, Jeong Sig Kim, Gyu Yeon Choi, Jeong Jae Lee, Im Soon Lee

After correction: Changes are marked by underlines.

Bo Ra Park, Haena Park, Ji Back Jung, Eun Sil Lee, Jeong Sig Kim, Gyu Yeon Choi, Jeong Jae Lee, Im Soon Lee

Article information Continued

Articles published in Obstet Gynecol Sci are open-access, distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.